Andrew Farach Download Headshot

Andrew Farach, MD

  • Houston Methodist radiation oncologist
  • Assistant professor of clinical radiation oncology, Weill Cornell Medical College
Media Contact: Amy Rose , 412.613.1428

Andrew Farach, MD

Request Interview
Media Contact: Amy Rose , 412.613.1428

Areas of Expertise

  • Brachytherapy
  • Gynecologic cancer (cervical, ovarian)
  • Lung cancer
  • Prostate cancer
  • Radiation therapy
  • Radiation/immunotherapy for breast cancer
  • Stereotactic radiation therapy

Credentials

RESIDENCY
Baylor College of Medicine- Houston, TX
MEDICAL SCHOOL
Thomas Jefferson University Jefferson Medical College-Philadelphia, PA | 2010
INTERNSHIP
University of Texas Health Science Center- Houston, TX

Publications

Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C, Ranganathan, S, Haque, W, Huang, E, Xu, J, Kulkarni, GS, Geng, M, Anis, M, Muhammad, T, Chan, KS, Farach, A, Teh, BS, Miles, BJ, Klaassen, Z, Sonpavde, GP, Wallis, CJD & Satkunasivam, R 2024, , Journal of the Canadian Urological Association, vol. 18, no. 2, pp. 17-24. https://doi.org/10.5489/cuaj.8386

Microfluidic coaxial 3D bioprinting of cell-laden microfibers and microtubes for salivary gland tissue engineering
Yin, Y, Vázquez-Rosado, EJ, Wu, D, Viswananthan, V, Farach, A, Farach-Carson, MC & Harrington, DA 2023, , Biomaterials Advances, vol. 154, 213588. https://doi.org/10.1016/j.bioadv.2023.213588

Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor
Hunt, A, Haque, W, Pino, R, Farach, A, Butler, EB & Teh, BS 2023, , Anticancer Research, vol. 43, no. 8, pp. 3539-3542. https://doi.org/10.21873/anticanres.16531


Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2023, , Clinical and Translational Radiation Oncology, vol. 39, 100592, pp. 100592. https://doi.org/10.1016/j.ctro.2023.100592

Leptomeningeal metastasis from neuroendocrine carcinoma of the cervix: illustrative case
Patterson, JD, Farach, AM, Singh, M, Britz, GW & Rostomily, RC 2023, , Journal of Neurosurgery: Case Lessons, vol. 5, no. 5, CASE22457. https://doi.org/10.3171/CASE22457

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J, Sun, K, Guerrero, CA, Zheng, J, Xu, Y, Mathur, S, Teh, BS, Farach, A, Zhang, J, Butler, E, Pan, PY, Zsigmond, E, Mei, Z, Mejia, J, Chen, SH, Chang, JC & Bernicker, EH 2023, , International Journal of Radiation Oncology Biology Physics, vol. 118, no. 5, pp. 1531-1540. https://doi.org/10.1016/j.ijrobp.2023.08.044

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
Sun, K, Xu, Y, Zhang, L, Niravath, P, Darcourt, J, Patel, T, Teh, BS, Farach, AM, Guerrero, C, Mathur, S, Sultenfuss, MA, Gupta, N, Schwartz, MR, Haley, SL, Nair, S, Li, X, Nguyen, TTA, Butner, JD, Ensor, J, Mejia, JA, Mei, Z, Butler, EB, Chen, SH, Bernicker, EH & Chang, JC 2022, , Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 28, no. 20, pp. 4392-4401. https://doi.org/10.1158/1078-0432.CCR-22-0622, https://doi.org/10.1158/1078-0432.CCR-22-0622

Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma
Chevli, N, Wang, K, Haque, W, Schwartz, MR, Nangia, J, Sasaki, J, Farach, AM, Hatch, SS, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer, vol. 22, no. 7, pp. e807-e817. https://doi.org/10.1016/j.clbc.2022.06.005


A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial
Satkunasivam, R, Lim, K, Teh, BS, Guzman, J, Zhang, J, Farach, A, Chen, SH, Wallis, CJD, Efstathiou, E, Esnaola, NF & Sonpavde, GP 2022, , Future Oncology, vol. 18, no. 25, pp. 2771-2781. https://doi.org/10.2217/fon-2022-0380

Localized prostate cancer: An analysis of the Centers for Disease Control and Prevention Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP)
Celtik, K, Wallis, CJD, Lo, M, Lim, K, Lipscomb, J, Fleming, S, Wu, XC, Anderson, RT, Thompson, TD, Farach, A, Hamilton, AS, Miles, BJ & Satkunasivam, R 2022, , Journal of the Canadian Urological Association, vol. 16, no. 7, pp. E391-E398. https://doi.org/10.5489/cuaj.7580

Contemporary trends in management of uveal melanoma
Chevli, N, Zuhour, RJ, Messer, JA, Haque, W, Schefler, AC, Bernicker, EH, Chevez-Barrios, P, Farach, AM, Butler, EB & Teh, BS 2022, , Journal of Contemporary Brachytherapy, vol. 14, no. 2, pp. 123-129. https://doi.org/10.5114/jcb.2022.115210

Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer
Chevli, N, Haque, W, Tran, KT, Farach, AM, Schwartz, MR, Hatch, SS, Butler, EB & Teh, BS 2023, , Practical Radiation Oncology, vol. 13, no. 3, pp. e230-e238. https://doi.org/10.1016/j.prro.2022.08.004

A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques
Patel, A, Orakwue, CW, Olek, D, Guzman, JCA, Lim, K, Pino, R, Teh, BS, Butler, B, Satkunasivam, R & Farach, A 2023, , Brachytherapy, vol. 22, no. 2, pp. 195-198. https://doi.org/10.1016/j.brachy.2022.08.014

Time Interval to Initiation of Whole-Brain Radiation Therapy in Patients With Small Cell Lung Cancer With Brain Metastasis
Chevli, N, Hunt, A, Haque, W, Farach, AM, Messer, JA, Sukpraprut-Braaten, S, Bernicker, EH, Zhang, J, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100783. https://doi.org/10.1016/j.adro.2021.100783

Prognostic Impact of Biologically Equivalent Dose in Stereotactic Body Radiation Therapy for Renal Cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e262. https://doi.org/10.1016/j.ijrobp.2021.07.862

Postmastectomy Radiation Therapy Following Pathologic Complete Nodal Response to Neoadjuvant Chemotherapy
Haque, W, Verma, V, Teh, BS, Butler, EB, Hatch, SS, Desai, M, Arentz, SC, Jain, D, Schwartz, MR, Chevli, N & Farach, AM 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e196. https://doi.org/10.1016/j.ijrobp.2021.07.707

21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer
Chevli, NC, Haque, W, Tran, KT, Farach, AM, Schwartz, MR, Geyer, CE, Hatch, SS, Butler, EB & Teh, BS 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e205. https://doi.org/10.1016/j.ijrobp.2021.07.728

DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma
Chevli, N, Chiang, S, Farach, AM, Haque, W, Satkunasivam, R, Bernicker, EH, Pino, R, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100719. https://doi.org/10.1016/j.adro.2021.100719, https://doi.org/10.1016/j.adro.2021.100719

Languages

  • English